Please login to the form below

American Diabetes Association

This page shows the latest American Diabetes Association news and features for those working in and with pharma, biotech and healthcare.

Lilly’s Trulicity cuts heart and kidney risks in diabetes by 12%

Lilly revealed last November that the top-line data with the once-weekly GLP-1 agonist was positive, and over the weekend at the American Diabetes Association meeting, presented the detailed ... without established cardiovascular disease, a population

Latest news

AZ says Farxiga cuts kidney disease in type 2 diabetes

The results – presented at the American Diabetes Association congress and published in The Lancet Diabetes &Endocrinology – suggest that Farxiga could play a role in tackling both heart failure and kidney disease, ... These results emphasise the
J&J says real-world data finds no amputation risk for Invokana

A year ago, regulators slapped warnings to the labelling for Johnson &Johnson’s diabetes drug Invokana, setting it at a disadvantage against rival drugs in the SGLT2 inhibitor class, but now ... Now, J&J has data from a patient registry involving more
Daily Brief: Charity criticises NHSE and Vertex over Orkambi access, Sema scores again, NodThera launched

The field of diabetes is having its moment in the sun, as the American Diabetes Association 78. ... The company says its novel platform could bring new treatment options to patients in areas of unmet need in chronic inflammation, including
Alexa: find Novo Nordisk voice-activated diabetes tech

Novo Nordisk’s plans to harness voice-activated technology such as Amazon’s Alexa to improve diabetes care have taken a step forward. ... The $50, 000 first prize was awarded in late 2017 to Lighthouse, which operates in partnership with the American
Trial of J&J's canagliflozin boosts SGLT2 cardiovascular credentials

type 2 diabetes patients, but with an increased risk of lower-limb amputation. ... The results of the CANVAS trial - presented at the American Diabetes Association meeting in San Diego - showed that Invokana (canagliflozin) reduced cardiovascular death,

More from news
Approximately 2 fully matching, plus 57 partially matching documents found.

Latest Intelligence

The fight for affordable insulin

T1International. Elizabeth Pfiester is the founder of T1International, an advocacy organisation aimed at helping people with type 1 diabetes worldwide overcome problems of access to affordable insulin supplies. ... The movement is also distancing itself
Interview: Phil Southerland, Team Novo Nordisk

It hit home at the American Diabetes Association conference this year, where I had a number of colleagues who said how much it meant to them how we were all type ... 1. It was proof that anything is possible even if you have diabetes.
Case study: Educating HCPs and patients about diabetes

Premiering at the American Diabetes Association Scientific Sessions, the play and expert panel examined and discussed the link between weight, cardiovascular disease and T2D. ... The live play and panel discussion premiered at the annual meetings of the

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

Walgreens’ head of pharmacy to step down

On top of this Crawford will serve as national chair for the American Diabetes Association's new Ad Council campaign across the country.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

World Diabetes Day: Interaction and impact of diabetes on mental health

Depressive symptoms and mortality among persons with and without diabetes. American Journal of Epidemiology, 161(7), pp.652-660. ... and Peyrot, M., 2016. Psychosocial care for people with diabetes: a position statement of the American Diabetes

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Could formulary intelligence be your brand differentiator?: Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
How COVID-19 is accelerating the threat of antimicrobial resistance: Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping: Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...